
Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Figure out how to Guarantee Your Dental Embeds Endure forever - 2
7 Fast Approaches to Let loose Space on Your Telephone in a flash - 3
New findings suggest atmosphere could exist on exoplanet TOI-561b - 4
Watch Chinese astronauts enjoy '1st ever space BBQ' from Tiangong's brand-new oven (video) - 5
Top 20 Wellbeing and Wellness Applications for a Sound Way of life
I took my shoes off and went for a barefoot hike. I couldn’t believe what happened next
Moving Wedding Objections for Paramount Functions
Study finds humans were making fire 400,000 years ago, far earlier than once thought
Bring tissues and skip the mascara: The movie that's making theater-goers sob uncontrollaby
COGAT discovers motor oil hidden inside UN's humanitarian aid to Gaza in smuggling attempt
10 Fundamental Tips and Deceives to Lift Your Cell phone's Exhibition
Grasping Various Kinds of Local misdemeanors
FDA approves Wegovy pill for weight loss
Pfizer says patient dies after receiving hemophilia drug in trial













